ANI Pharmaceuticals Slips To Loss In Q3, But Results Above Estimates - Quick Facts

Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Monday a third-quarter net loss of $4.45 million or $0.37 per share, compared to net income of $0.43 million or $0.04 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter was $1.01 per share, compared to $ 0.97 per share in the year-ago quarter.

Net revenues for the quarter edged down to $52.06 million from $52.98 million in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.70 per share on revenues of $49.7 million for the quarter. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT